Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;8(4):185-194.
doi: 10.1007/s40135-020-00257-7. Epub 2020 Sep 26.

Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019

Affiliations
Review

Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019

Kai Xiong Cheong. Curr Ophthalmol Rep. 2020.

Abstract

Purpose of review: Studies have reported ocular involvement in the coronavirus disease 2019 (COVID-19), with SARS-CoV-2 having been detected in ocular swab samples. This has implicated the eye as a portal of transmission. The aim of this systemic review is to summarise and discuss the current literature regarding ocular involvement of SARS-CoV-2 in COVID-19.

Recent findings: In this systematic review, the prevalence of ocular symptoms and signs was low (from 0 to 31.58%) and conjunctivitis was a relatively rare occurrence. The rate of detection of SARS-CoV-2 in the ocular swab samples was low as well and this ranged from 0 to 11.11%. The development of ocular symptoms and signs was not always accompanied by the detection of SARS-CoV-2 in the ocular swab samples. The opposite was described as well. This may reflect issues related to the characteristics of SARS-CoV-2 and of the study design. Nonetheless, the nature of research in a pandemic is that conclusions can change as more information is obtained.

Summary: Whilst the eye is unlikely to be a main transmission route, we need to consider the possibilities of conjunctivitis as a presenting complaint and of the eye playing a role in the transmission of SARS-CoV-2. Furthermore, we need to take the appropriate precautions in our practice. Further studies are needed to evaluate the viral tropism of SARS-CoV-2 and its role in the eyes.

Keywords: Conjunctiva; Coronavirus disease 2019; Reverse transcription polymerase chain reaction; SARS-CoV-2; Tears; Transmission; Viral culture.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe author declares that he has no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA flowchart

References

    1. World Health Organization. Situation reports July 2020. In: Coronavirus disease (COVID-2019) situation reports. World Health Organization. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio.... Accessed 17 Jul 2020.
    1. Amirian ES. Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. Int J Infect Dis. 2020;95:363–370. doi: 10.1016/j.ijid.2020.04.057. - DOI - PMC - PubMed
    1. Holshue ML, DeBolt C, Lindquist S. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929–936. doi: 10.1056/NEJMoa2001191. - DOI - PMC - PubMed
    1. Zhou Y, Duan C, Zeng Y, Tong Y, Nie Y, Yang Y, Chen Z, Chen C. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127:982–983. doi: 10.1016/j.ophtha.2020.04.028. - DOI - PMC - PubMed
    1. Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, Yu H, Chen B, Sun X. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18:360–362. doi: 10.1016/j.jtos.2020.03.010. - DOI - PMC - PubMed

LinkOut - more resources